Role of Decreased Expression of MiR-155 and MiR-146a in Peripheral Blood of Type 2 Diabetes Mellitus Patients with Diabetic Peripheral Neuropathy [Letter]
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sayed A, Gomaa I, Bader M, El Sayed N
. Role of 3-Acetyl-11-Keto-Beta-Boswellic Acid in Counteracting LPS-Induced Neuroinflammation via Modulation of miRNA-155. Mol Neurobiol. 2017; 55(7):5798-5808.
DOI: 10.1007/s12035-017-0801-2.
View
2.
Yin X, Xu C, Xu Q, Lang D
. Docosahexaenoic acid inhibits vascular smooth muscle cell migration and proliferation by decreasing microRNA‑155 expression levels. Mol Med Rep. 2020; 22(4):3396-3404.
PMC: 7453611.
DOI: 10.3892/mmr.2020.11404.
View
3.
Ji H, Lu Y, Liu G, Zhao X, Xu M, Chen M
. Role of Decreased Expression of miR-155 and miR-146a in Peripheral Blood of Type 2 Diabetes Mellitus Patients with Diabetic Peripheral Neuropathy. Diabetes Metab Syndr Obes. 2024; 17:2747-2760.
PMC: 11283243.
DOI: 10.2147/DMSO.S467409.
View
4.
Wang L, Liu P, Han Y
. Serum microRNA-181a Expression Level in Patients with Acute Liver Failure and Its Correlation with Prognosis. Int J Gen Med. 2024; 17:4815-4822.
PMC: 11495206.
DOI: 10.2147/IJGM.S478709.
View
5.
Akollo I
. Prevalence and Antimicrobial Sensitivity Patterns of Uropathogens in Wad Medani, Sudan: A Three Year, Cross-Sectional Study [Letter]. Infect Drug Resist. 2024; 17:2623-2624.
PMC: 11214569.
DOI: 10.2147/IDR.S483116.
View